Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
Orano Med LLC
Orano Med LLC
National Cancer Institute (NCI)
Prelude Therapeutics
ABM Therapeutics Corporation
Sumitomo Pharma America, Inc.
Quadriga Biosciences, Inc.
Celgene
Tocagen Inc.
Merck Sharp & Dohme LLC
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
Pharmacyclics LLC.